ConductScience.org, home

Paper41567906

Prevalence and Patterns of Dyslipidemia Among Patients With Rheumatoid Arthritis: A Retrospective Cohort Study.

Aldhuhoori MM and 3 others. Cureus, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Prevalence and Patterns of Dyslipidemia Among Patients With Rheumatoid Arthritis: A Retrospective Cohort Study. Papers, record 41567906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41567906

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevalence and Patterns of Dyslipidemia Among Patients With Rheumatoid Arthritis: A Retrospective Cohort Study.
PubMed
Journal
Cureus
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-01-24
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aldhuhoori MMMuna M
2Makki IIbtehal
3Alnuaimi MMaryam
4Lootah FFatima

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138216289When does obesity exert its effect in conferring risk of developing RA: a large study in cohorts of symptomatic persons at risk.RMD Open2024https://conductscience.org/library/papers/38216289PubMed
239532347Prevalence of comorbidities among patients with rheumatoid arthritis in the UAE: a case-control study.BMJ Open2024https://conductscience.org/library/papers/39532347PubMed
326458977High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study.Arthritis Res Ther2015https://conductscience.org/library/papers/26458977PubMed
419854708Total cholesterol and LDL levels decrease before rheumatoid arthritis.Ann Rheum Dis2010https://conductscience.org/library/papers/19854708PubMed
535628831Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022.J Clin Med2022https://conductscience.org/library/papers/35628831PubMed
633060323The Prevalence of Rheumatoid Arthritis: A Systematic Review of Population-based Studies.J Rheumatol2021https://conductscience.org/library/papers/33060323PubMed
738326904The association between remnant cholesterol and rheumatoid arthritis: insights from a large population study.Lipids Health Dis2024https://conductscience.org/library/papers/38326904PubMed
822991486Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals.Mediators Inflamm2012https://conductscience.org/library/papers/22991486PubMed
916855148Epidemiological aspects of rheumatoid arthritis: the sex ratio.Ann N Y Acad Sci2006https://conductscience.org/library/papers/16855148PubMed
1034685413Ischemic Heart Disease and Rheumatoid Arthritis-Two Conditions, the Same Background.Life (Basel)2021https://conductscience.org/library/papers/34685413PubMed
1137600807Rheumatoid arthritis and hypothyroidism: a bidirectional Mendelian randomization study.Front Immunol2023https://conductscience.org/library/papers/37600807PubMed
1231511227Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017.Ann Rheum Dis2019https://conductscience.org/library/papers/31511227PubMed
1336836675Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy.Life (Basel)2023https://conductscience.org/library/papers/36836675PubMed
1436357155EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.Ann Rheum Dis2023https://conductscience.org/library/papers/36357155PubMed
1534095011Immunologic Aspects of Dyslipidemia: a Critical Regulator of Adaptive Immunity and Immune Disorders.J Lipid Atheroscler2021https://conductscience.org/library/papers/34095011PubMed
1627156434Rheumatoid arthritis.Lancet2016https://conductscience.org/library/papers/27156434PubMed
1721778898The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis.J Clin Rheumatol2011https://conductscience.org/library/papers/21778898PubMed
1839048336Exploring Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis.Eur J Intern Med2024https://conductscience.org/library/papers/39048336PubMed
1937325667Lipid metabolism and rheumatoid arthritis.Front Immunol2023https://conductscience.org/library/papers/37325667PubMed
2037954591Dyslipidemia in rheumatoid arthritis: the possible mechanisms.Front Immunol2023https://conductscience.org/library/papers/37954591PubMed

See all 26 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41567906

GET https://conductscience.org/api/papers/v1/41567906/references?page=2